Doctors Note Logo

Published on: 8/20/2026

Does izervay work immediately?

Izervay does not restore vision or produce immediate results. It is a prescription eye injection approved to slow the progression of geographic atrophy (GA), an advanced form of age-related macular degeneration. Benefits develop gradually with continued monthly treatment, as measured by slower lesion growth on retinal imaging rather than noticeable day-to-day vision changes.

If you're experiencing blurred spots, distorted vision, or difficulty seeing in low light, don't wait to find out what's behind it. Early identification of geographic atrophy and related conditions gives you more treatment options and better long-term outcomes. Take a free, instant, online symptom check to better understand your symptoms and confidently plan your next steps with a healthcare provider.

Reviewed for medical accuracy: 07/15/2026

answer background

Quick answers

Frequently Asked Questions

4 answers

The most common questions people search after this page

Concerned about your symptoms?

Explanation

Izervay, also known as avacincaptad pegol, is a treatment to help slow vision loss in patients with geographic atrophy rather than to fix vision right away. After you receive an injection, the medicine begins working at a cellular level to help protect and preserve your vision. However, you will not notice a quick or immediate improvement in how you see. Instead, over many months of treatment, Izervay can reduce the speed at which vision loss happens. This treatment works gradually by targeting processes in the eye that lead to damage. It is similar to some other medicines where the benefit is seen by the long-term slowing of a disease's progress. Because of this gradual effect, it is very important to follow up with your eye doctor regularly during treatment so they can monitor your condition and adjust care as needed. Remember, if you have any questions about your treatment or if you're experiencing concerning symptoms, you can check your symptoms with our free AI-powered tool and discuss the results with your healthcare provider.

(References)

  • Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. PMID: 37696275.

  • Shakeel L, Khan A, Akilimali A. "Izervay (avacincaptad pegol): paving the way for vision preservation in geographic atrophy". Ann Med Surg (Lond). 2024 Apr 3;86(5):2413-2416. doi: 10.1097/MS9.0000000000002021. PMID: 38694318; PMCID: PMC11060312.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.